BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33910596)

  • 1. Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities.
    Zamudio-Martinez E; Herrera-Campos AB; Muñoz A; Rodríguez-Vargas JM; Oliver FJ
    J Exp Clin Cancer Res; 2021 Apr; 40(1):144. PubMed ID: 33910596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBM Hunter: Identify and Score Canonical, Extended, and Unconventional Tankyrase-Binding Motifs in Any Protein.
    Clements CM; Shellman SX; Shellman MH; Shellman YG
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into SAM domain-mediated tankyrase oligomerization.
    DaRosa PA; Ovchinnikov S; Xu W; Klevit RE
    Protein Sci; 2016 Sep; 25(9):1744-52. PubMed ID: 27328430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The zinc-binding motif in tankyrases is required for the structural integrity of the catalytic ADP-ribosyltransferase domain.
    Sowa ST; Lehtiö L
    Open Biol; 2022 Mar; 12(3):210365. PubMed ID: 35317661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic roles of tankyrase/PARP proteins in the establishment and maintenance of human naïve pluripotency.
    Zimmerlin L; Zambidis ET
    Exp Cell Res; 2020 May; 390(1):111935. PubMed ID: 32151493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights of tankyrases: A novel target for drug discovery.
    Damale MG; Pathan SK; Shinde DB; Patil RH; Arote RB; Sangshetti JN
    Eur J Med Chem; 2020 Dec; 207():112712. PubMed ID: 32877803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for tankyrase-RNF146 interaction reveals noncanonical tankyrase-binding motifs.
    DaRosa PA; Klevit RE; Xu W
    Protein Sci; 2018 Jun; 27(6):1057-1067. PubMed ID: 29604130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tankyrase: a promising therapeutic target with pleiotropic action.
    Sagathia V; Patel C; Beladiya J; Patel S; Sheth D; Shah G
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3363-3374. PubMed ID: 37338576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1.
    Deng Z; Atanasiu C; Zhao K; Marmorstein R; Sbodio JI; Chi NW; Lieberman PM
    J Virol; 2005 Apr; 79(8):4640-50. PubMed ID: 15795250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions.
    Kirubakaran P; Kothandan G; Cho SJ; Muthusamy K
    Mol Biosyst; 2014 Feb; 10(2):281-93. PubMed ID: 24291818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of tankyrase activity by a catalytic domain dimer interface.
    Fan C; Yarravarapu N; Chen H; Kulak O; Dasari P; Herbert J; Yamaguchi K; Lum L; Zhang X
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1780-1785. PubMed ID: 30055800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tankyrase1-mediated poly(ADP-ribosyl)ation of TRF1 maintains cell survival after telomeric DNA damage.
    Yang L; Sun L; Teng Y; Chen H; Gao Y; Levine AS; Nakajima S; Lan L
    Nucleic Acids Res; 2017 Apr; 45(7):3906-3921. PubMed ID: 28160604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tankyrase Sterile α Motif Domain Polymerization Is Required for Its Role in Wnt Signaling.
    Riccio AA; McCauley M; Langelier MF; Pascal JM
    Structure; 2016 Sep; 24(9):1573-81. PubMed ID: 27499439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution NMR assignment of the ARC4 domain of human tankyrase 2.
    Zaleska M; Pollock K; Collins I; Guettler S; Pfuhl M
    Biomol NMR Assign; 2019 Apr; 13(1):255-260. PubMed ID: 30847846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta.
    Martino-Echarri E; Brocardo MG; Mills KM; Henderson BR
    PLoS One; 2016; 11(3):e0150484. PubMed ID: 26930278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying and Validating Tankyrase Binders and Substrates: A Candidate Approach.
    Pollock K; Ranes M; Collins I; Guettler S
    Methods Mol Biol; 2017; 1608():445-473. PubMed ID: 28695526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a tankyrase 1-telomere repeat factor 1 complex.
    Li B; Qiao R; Wang Z; Zhou W; Li X; Xu W; Rao Z
    Acta Crystallogr F Struct Biol Commun; 2016 Apr; 72(Pt 4):320-7. PubMed ID: 27050267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase.
    Koirala S; Klein J; Zheng Y; Glenn NO; Eisemann T; Fon Tacer K; Miller DJ; Kulak O; Lu M; Finkelstein DB; Neale G; Tillman H; Vogel P; Strand DW; Lum L; Brautigam CA; Pascal JM; Clements WK; Potts PR
    Cell Rep; 2020 Jul; 32(3):107922. PubMed ID: 32698014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel binding mode of a potent and selective tankyrase inhibitor.
    Gunaydin H; Gu Y; Huang X
    PLoS One; 2012; 7(3):e33740. PubMed ID: 22438990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-based screening identifies molecules targeting the substrate-binding ankyrin repeat domains of tankyrase.
    Pollock K; Liu M; Zaleska M; Meniconi M; Pfuhl M; Collins I; Guettler S
    Sci Rep; 2019 Dec; 9(1):19130. PubMed ID: 31836723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.